
Global TNF Inhibitors for the Treatment of Plaque Psoriasis Industry Growth and Trends Forecast to 2031
Description
Summary
According to APO Research, The global TNF Inhibitors for the Treatment of Plaque Psoriasis market was estimated at US$ million in 2025 and is projected to reach a revised size of US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2026-2031.
North American market for TNF Inhibitors for the Treatment of Plaque Psoriasis is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.
Asia-Pacific market for TNF Inhibitors for the Treatment of Plaque Psoriasis is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.
Europe market for TNF Inhibitors for the Treatment of Plaque Psoriasis is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.
The major global manufacturers of TNF Inhibitors for the Treatment of Plaque Psoriasis include Chia Tai Tianqing Pharmaceutical, Innovent Biologics, Sino Cell Technologies, Samsung Bioepis, Hangzhou Bozhirui Biopharmaceuticals, Hisun Pharmaceuticals, Bio-Thera Solutions, YL Biologics and UCB, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for TNF Inhibitors for the Treatment of Plaque Psoriasis, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding TNF Inhibitors for the Treatment of Plaque Psoriasis.
The TNF Inhibitors for the Treatment of Plaque Psoriasis market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global TNF Inhibitors for the Treatment of Plaque Psoriasis market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.
TNF Inhibitors for the Treatment of Plaque Psoriasis Segment by Company
Chia Tai Tianqing Pharmaceutical
Innovent Biologics
Sino Cell Technologies
Samsung Bioepis
Hangzhou Bozhirui Biopharmaceuticals
Hisun Pharmaceuticals
Bio-Thera Solutions
YL Biologics
UCB
Teva
Sandoz
Pfizer
Janssen Biotech
Coherus BioSciences
Celltrion
Boehringer Ingelheim Pharmaceuticals
Biocon Biologics
Amgen
AbbVie
TNF Inhibitors for the Treatment of Plaque Psoriasis Segment by Type
Adalimumab
Certolizumab pegol
Etanercept
Infliximab
Other
TNF Inhibitors for the Treatment of Plaque Psoriasis Segment by Application
Hospital and Clinic
Retail Pharmacies
Other
TNF Inhibitors for the Treatment of Plaque Psoriasis Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global TNF Inhibitors for the Treatment of Plaque Psoriasis market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of TNF Inhibitors for the Treatment of Plaque Psoriasis and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of TNF Inhibitors for the Treatment of Plaque Psoriasis.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of TNF Inhibitors for the Treatment of Plaque Psoriasis manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of TNF Inhibitors for the Treatment of Plaque Psoriasis in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.
According to APO Research, The global TNF Inhibitors for the Treatment of Plaque Psoriasis market was estimated at US$ million in 2025 and is projected to reach a revised size of US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2026-2031.
North American market for TNF Inhibitors for the Treatment of Plaque Psoriasis is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.
Asia-Pacific market for TNF Inhibitors for the Treatment of Plaque Psoriasis is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.
Europe market for TNF Inhibitors for the Treatment of Plaque Psoriasis is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.
The major global manufacturers of TNF Inhibitors for the Treatment of Plaque Psoriasis include Chia Tai Tianqing Pharmaceutical, Innovent Biologics, Sino Cell Technologies, Samsung Bioepis, Hangzhou Bozhirui Biopharmaceuticals, Hisun Pharmaceuticals, Bio-Thera Solutions, YL Biologics and UCB, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for TNF Inhibitors for the Treatment of Plaque Psoriasis, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding TNF Inhibitors for the Treatment of Plaque Psoriasis.
The TNF Inhibitors for the Treatment of Plaque Psoriasis market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global TNF Inhibitors for the Treatment of Plaque Psoriasis market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.
TNF Inhibitors for the Treatment of Plaque Psoriasis Segment by Company
Chia Tai Tianqing Pharmaceutical
Innovent Biologics
Sino Cell Technologies
Samsung Bioepis
Hangzhou Bozhirui Biopharmaceuticals
Hisun Pharmaceuticals
Bio-Thera Solutions
YL Biologics
UCB
Teva
Sandoz
Pfizer
Janssen Biotech
Coherus BioSciences
Celltrion
Boehringer Ingelheim Pharmaceuticals
Biocon Biologics
Amgen
AbbVie
TNF Inhibitors for the Treatment of Plaque Psoriasis Segment by Type
Adalimumab
Certolizumab pegol
Etanercept
Infliximab
Other
TNF Inhibitors for the Treatment of Plaque Psoriasis Segment by Application
Hospital and Clinic
Retail Pharmacies
Other
TNF Inhibitors for the Treatment of Plaque Psoriasis Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global TNF Inhibitors for the Treatment of Plaque Psoriasis market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of TNF Inhibitors for the Treatment of Plaque Psoriasis and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of TNF Inhibitors for the Treatment of Plaque Psoriasis.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of TNF Inhibitors for the Treatment of Plaque Psoriasis manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of TNF Inhibitors for the Treatment of Plaque Psoriasis in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.
Table of Contents
110 Pages
- 1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global TNF Inhibitors for the Treatment of Plaque Psoriasis Market Size Estimates and Forecasts (2020-2031)
- 1.2.2 Global TNF Inhibitors for the Treatment of Plaque Psoriasis Sales Estimates and Forecasts (2020-2031)
- 1.3 TNF Inhibitors for the Treatment of Plaque Psoriasis Market by Type
- 1.3.1 Adalimumab
- 1.3.2 Certolizumab pegol
- 1.3.3 Etanercept
- 1.3.4 Infliximab
- 1.3.5 Other
- 1.4 Global TNF Inhibitors for the Treatment of Plaque Psoriasis Market Size by Type
- 1.4.1 Global TNF Inhibitors for the Treatment of Plaque Psoriasis Market Size Overview by Type (2020-2031)
- 1.4.2 Global TNF Inhibitors for the Treatment of Plaque Psoriasis Historic Market Size Review by Type (2020-2025)
- 1.4.3 Global TNF Inhibitors for the Treatment of Plaque Psoriasis Forecasted Market Size by Type (2026-2031)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America TNF Inhibitors for the Treatment of Plaque Psoriasis Sales Breakdown by Type (2020-2025)
- 1.5.2 Europe TNF Inhibitors for the Treatment of Plaque Psoriasis Sales Breakdown by Type (2020-2025)
- 1.5.3 Asia-Pacific TNF Inhibitors for the Treatment of Plaque Psoriasis Sales Breakdown by Type (2020-2025)
- 1.5.4 South America TNF Inhibitors for the Treatment of Plaque Psoriasis Sales Breakdown by Type (2020-2025)
- 1.5.5 Middle East and Africa TNF Inhibitors for the Treatment of Plaque Psoriasis Sales Breakdown by Type (2020-2025)
- 2 Global Market Dynamics
- 2.1 TNF Inhibitors for the Treatment of Plaque Psoriasis Industry Trends
- 2.2 TNF Inhibitors for the Treatment of Plaque Psoriasis Industry Drivers
- 2.3 TNF Inhibitors for the Treatment of Plaque Psoriasis Industry Opportunities and Challenges
- 2.4 TNF Inhibitors for the Treatment of Plaque Psoriasis Industry Restraints
- 3 Market Competitive Landscape by Company
- 3.1 Global Top Players by TNF Inhibitors for the Treatment of Plaque Psoriasis Revenue (2020-2025)
- 3.2 Global Top Players by TNF Inhibitors for the Treatment of Plaque Psoriasis Sales (2020-2025)
- 3.3 Global Top Players by TNF Inhibitors for the Treatment of Plaque Psoriasis Price (2020-2025)
- 3.4 Global TNF Inhibitors for the Treatment of Plaque Psoriasis Industry Company Ranking, 2023 VS 2024 VS 2025
- 3.5 Global TNF Inhibitors for the Treatment of Plaque Psoriasis Major Company Production Sites & Headquarters
- 3.6 Global TNF Inhibitors for the Treatment of Plaque Psoriasis Company, Product Type & Application
- 3.7 Global TNF Inhibitors for the Treatment of Plaque Psoriasis Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global TNF Inhibitors for the Treatment of Plaque Psoriasis Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 TNF Inhibitors for the Treatment of Plaque Psoriasis Players Market Share by Revenue in 2024
- 3.8.3 2023 TNF Inhibitors for the Treatment of Plaque Psoriasis Tier 1, Tier 2, and Tier 3
- 4 TNF Inhibitors for the Treatment of Plaque Psoriasis Regional Status and Outlook
- 4.1 Global TNF Inhibitors for the Treatment of Plaque Psoriasis Market Size and CAGR by Region: 2020 VS 2024 VS 2031
- 4.2 Global TNF Inhibitors for the Treatment of Plaque Psoriasis Historic Market Size by Region
- 4.2.1 Global TNF Inhibitors for the Treatment of Plaque Psoriasis Sales in Volume by Region (2020-2025)
- 4.2.2 Global TNF Inhibitors for the Treatment of Plaque Psoriasis Sales in Value by Region (2020-2025)
- 4.2.3 Global TNF Inhibitors for the Treatment of Plaque Psoriasis Sales (Volume & Value), Price and Gross Margin (2020-2025)
- 4.3 Global TNF Inhibitors for the Treatment of Plaque Psoriasis Forecasted Market Size by Region
- 4.3.1 Global TNF Inhibitors for the Treatment of Plaque Psoriasis Sales in Volume by Region (2026-2031)
- 4.3.2 Global TNF Inhibitors for the Treatment of Plaque Psoriasis Sales in Value by Region (2026-2031)
- 4.3.3 Global TNF Inhibitors for the Treatment of Plaque Psoriasis Sales (Volume & Value), Price and Gross Margin (2026-2031)
- 5 TNF Inhibitors for the Treatment of Plaque Psoriasis by Application
- 5.1 TNF Inhibitors for the Treatment of Plaque Psoriasis Market by Application
- 5.1.1 Hospital and Clinic
- 5.1.2 Retail Pharmacies
- 5.1.3 Other
- 5.2 Global TNF Inhibitors for the Treatment of Plaque Psoriasis Market Size by Application
- 5.2.1 Global TNF Inhibitors for the Treatment of Plaque Psoriasis Market Size Overview by Application (2020-2031)
- 5.2.2 Global TNF Inhibitors for the Treatment of Plaque Psoriasis Historic Market Size Review by Application (2020-2025)
- 5.2.3 Global TNF Inhibitors for the Treatment of Plaque Psoriasis Forecasted Market Size by Application (2026-2031)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America TNF Inhibitors for the Treatment of Plaque Psoriasis Sales Breakdown by Application (2020-2025)
- 5.3.2 Europe TNF Inhibitors for the Treatment of Plaque Psoriasis Sales Breakdown by Application (2020-2025)
- 5.3.3 Asia-Pacific TNF Inhibitors for the Treatment of Plaque Psoriasis Sales Breakdown by Application (2020-2025)
- 5.3.4 South America TNF Inhibitors for the Treatment of Plaque Psoriasis Sales Breakdown by Application (2020-2025)
- 5.3.5 Middle East and Africa TNF Inhibitors for the Treatment of Plaque Psoriasis Sales Breakdown by Application (2020-2025)
- 6 Company Profiles
- 6.1 Chia Tai Tianqing Pharmaceutical
- 6.1.1 Chia Tai Tianqing Pharmaceutical Comapny Information
- 6.1.2 Chia Tai Tianqing Pharmaceutical Business Overview
- 6.1.3 Chia Tai Tianqing Pharmaceutical TNF Inhibitors for the Treatment of Plaque Psoriasis Sales, Revenue and Gross Margin (2020-2025)
- 6.1.4 Chia Tai Tianqing Pharmaceutical TNF Inhibitors for the Treatment of Plaque Psoriasis Product Portfolio
- 6.1.5 Chia Tai Tianqing Pharmaceutical Recent Developments
- 6.2 Innovent Biologics
- 6.2.1 Innovent Biologics Comapny Information
- 6.2.2 Innovent Biologics Business Overview
- 6.2.3 Innovent Biologics TNF Inhibitors for the Treatment of Plaque Psoriasis Sales, Revenue and Gross Margin (2020-2025)
- 6.2.4 Innovent Biologics TNF Inhibitors for the Treatment of Plaque Psoriasis Product Portfolio
- 6.2.5 Innovent Biologics Recent Developments
- 6.3 Sino Cell Technologies
- 6.3.1 Sino Cell Technologies Comapny Information
- 6.3.2 Sino Cell Technologies Business Overview
- 6.3.3 Sino Cell Technologies TNF Inhibitors for the Treatment of Plaque Psoriasis Sales, Revenue and Gross Margin (2020-2025)
- 6.3.4 Sino Cell Technologies TNF Inhibitors for the Treatment of Plaque Psoriasis Product Portfolio
- 6.3.5 Sino Cell Technologies Recent Developments
- 6.4 Samsung Bioepis
- 6.4.1 Samsung Bioepis Comapny Information
- 6.4.2 Samsung Bioepis Business Overview
- 6.4.3 Samsung Bioepis TNF Inhibitors for the Treatment of Plaque Psoriasis Sales, Revenue and Gross Margin (2020-2025)
- 6.4.4 Samsung Bioepis TNF Inhibitors for the Treatment of Plaque Psoriasis Product Portfolio
- 6.4.5 Samsung Bioepis Recent Developments
- 6.5 Hangzhou Bozhirui Biopharmaceuticals
- 6.5.1 Hangzhou Bozhirui Biopharmaceuticals Comapny Information
- 6.5.2 Hangzhou Bozhirui Biopharmaceuticals Business Overview
- 6.5.3 Hangzhou Bozhirui Biopharmaceuticals TNF Inhibitors for the Treatment of Plaque Psoriasis Sales, Revenue and Gross Margin (2020-2025)
- 6.5.4 Hangzhou Bozhirui Biopharmaceuticals TNF Inhibitors for the Treatment of Plaque Psoriasis Product Portfolio
- 6.5.5 Hangzhou Bozhirui Biopharmaceuticals Recent Developments
- 6.6 Hisun Pharmaceuticals
- 6.6.1 Hisun Pharmaceuticals Comapny Information
- 6.6.2 Hisun Pharmaceuticals Business Overview
- 6.6.3 Hisun Pharmaceuticals TNF Inhibitors for the Treatment of Plaque Psoriasis Sales, Revenue and Gross Margin (2020-2025)
- 6.6.4 Hisun Pharmaceuticals TNF Inhibitors for the Treatment of Plaque Psoriasis Product Portfolio
- 6.6.5 Hisun Pharmaceuticals Recent Developments
- 6.7 Bio-Thera Solutions
- 6.7.1 Bio-Thera Solutions Comapny Information
- 6.7.2 Bio-Thera Solutions Business Overview
- 6.7.3 Bio-Thera Solutions TNF Inhibitors for the Treatment of Plaque Psoriasis Sales, Revenue and Gross Margin (2020-2025)
- 6.7.4 Bio-Thera Solutions TNF Inhibitors for the Treatment of Plaque Psoriasis Product Portfolio
- 6.7.5 Bio-Thera Solutions Recent Developments
- 6.8 YL Biologics
- 6.8.1 YL Biologics Comapny Information
- 6.8.2 YL Biologics Business Overview
- 6.8.3 YL Biologics TNF Inhibitors for the Treatment of Plaque Psoriasis Sales, Revenue and Gross Margin (2020-2025)
- 6.8.4 YL Biologics TNF Inhibitors for the Treatment of Plaque Psoriasis Product Portfolio
- 6.8.5 YL Biologics Recent Developments
- 6.9 UCB
- 6.9.1 UCB Comapny Information
- 6.9.2 UCB Business Overview
- 6.9.3 UCB TNF Inhibitors for the Treatment of Plaque Psoriasis Sales, Revenue and Gross Margin (2020-2025)
- 6.9.4 UCB TNF Inhibitors for the Treatment of Plaque Psoriasis Product Portfolio
- 6.9.5 UCB Recent Developments
- 6.10 Teva
- 6.10.1 Teva Comapny Information
- 6.10.2 Teva Business Overview
- 6.10.3 Teva TNF Inhibitors for the Treatment of Plaque Psoriasis Sales, Revenue and Gross Margin (2020-2025)
- 6.10.4 Teva TNF Inhibitors for the Treatment of Plaque Psoriasis Product Portfolio
- 6.10.5 Teva Recent Developments
- 6.11 Sandoz
- 6.11.1 Sandoz Comapny Information
- 6.11.2 Sandoz Business Overview
- 6.11.3 Sandoz TNF Inhibitors for the Treatment of Plaque Psoriasis Sales, Revenue and Gross Margin (2020-2025)
- 6.11.4 Sandoz TNF Inhibitors for the Treatment of Plaque Psoriasis Product Portfolio
- 6.11.5 Sandoz Recent Developments
- 6.12 Pfizer
- 6.12.1 Pfizer Comapny Information
- 6.12.2 Pfizer Business Overview
- 6.12.3 Pfizer TNF Inhibitors for the Treatment of Plaque Psoriasis Sales, Revenue and Gross Margin (2020-2025)
- 6.12.4 Pfizer TNF Inhibitors for the Treatment of Plaque Psoriasis Product Portfolio
- 6.12.5 Pfizer Recent Developments
- 6.13 Janssen Biotech
- 6.13.1 Janssen Biotech Comapny Information
- 6.13.2 Janssen Biotech Business Overview
- 6.13.3 Janssen Biotech TNF Inhibitors for the Treatment of Plaque Psoriasis Sales, Revenue and Gross Margin (2020-2025)
- 6.13.4 Janssen Biotech TNF Inhibitors for the Treatment of Plaque Psoriasis Product Portfolio
- 6.13.5 Janssen Biotech Recent Developments
- 6.14 Coherus BioSciences
- 6.14.1 Coherus BioSciences Comapny Information
- 6.14.2 Coherus BioSciences Business Overview
- 6.14.3 Coherus BioSciences TNF Inhibitors for the Treatment of Plaque Psoriasis Sales, Revenue and Gross Margin (2020-2025)
- 6.14.4 Coherus BioSciences TNF Inhibitors for the Treatment of Plaque Psoriasis Product Portfolio
- 6.14.5 Coherus BioSciences Recent Developments
- 6.15 Celltrion
- 6.15.1 Celltrion Comapny Information
- 6.15.2 Celltrion Business Overview
- 6.15.3 Celltrion TNF Inhibitors for the Treatment of Plaque Psoriasis Sales, Revenue and Gross Margin (2020-2025)
- 6.15.4 Celltrion TNF Inhibitors for the Treatment of Plaque Psoriasis Product Portfolio
- 6.15.5 Celltrion Recent Developments
- 6.16 Boehringer Ingelheim Pharmaceuticals
- 6.16.1 Boehringer Ingelheim Pharmaceuticals Comapny Information
- 6.16.2 Boehringer Ingelheim Pharmaceuticals Business Overview
- 6.16.3 Boehringer Ingelheim Pharmaceuticals TNF Inhibitors for the Treatment of Plaque Psoriasis Sales, Revenue and Gross Margin (2020-2025)
- 6.16.4 Boehringer Ingelheim Pharmaceuticals TNF Inhibitors for the Treatment of Plaque Psoriasis Product Portfolio
- 6.16.5 Boehringer Ingelheim Pharmaceuticals Recent Developments
- 6.17 Biocon Biologics
- 6.17.1 Biocon Biologics Comapny Information
- 6.17.2 Biocon Biologics Business Overview
- 6.17.3 Biocon Biologics TNF Inhibitors for the Treatment of Plaque Psoriasis Sales, Revenue and Gross Margin (2020-2025)
- 6.17.4 Biocon Biologics TNF Inhibitors for the Treatment of Plaque Psoriasis Product Portfolio
- 6.17.5 Biocon Biologics Recent Developments
- 6.18 Amgen
- 6.18.1 Amgen Comapny Information
- 6.18.2 Amgen Business Overview
- 6.18.3 Amgen TNF Inhibitors for the Treatment of Plaque Psoriasis Sales, Revenue and Gross Margin (2020-2025)
- 6.18.4 Amgen TNF Inhibitors for the Treatment of Plaque Psoriasis Product Portfolio
- 6.18.5 Amgen Recent Developments
- 6.19 AbbVie
- 6.19.1 AbbVie Comapny Information
- 6.19.2 AbbVie Business Overview
- 6.19.3 AbbVie TNF Inhibitors for the Treatment of Plaque Psoriasis Sales, Revenue and Gross Margin (2020-2025)
- 6.19.4 AbbVie TNF Inhibitors for the Treatment of Plaque Psoriasis Product Portfolio
- 6.19.5 AbbVie Recent Developments
- 7 North America by Country
- 7.1 North America TNF Inhibitors for the Treatment of Plaque Psoriasis Sales by Country
- 7.1.1 North America TNF Inhibitors for the Treatment of Plaque Psoriasis Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
- 7.1.2 North America TNF Inhibitors for the Treatment of Plaque Psoriasis Sales by Country (2020-2025)
- 7.1.3 North America TNF Inhibitors for the Treatment of Plaque Psoriasis Sales Forecast by Country (2026-2031)
- 7.2 North America TNF Inhibitors for the Treatment of Plaque Psoriasis Market Size by Country
- 7.2.1 North America TNF Inhibitors for the Treatment of Plaque Psoriasis Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
- 7.2.2 North America TNF Inhibitors for the Treatment of Plaque Psoriasis Market Size by Country (2020-2025)
- 7.2.3 North America TNF Inhibitors for the Treatment of Plaque Psoriasis Market Size Forecast by Country (2026-2031)
- 8 Europe by Country
- 8.1 Europe TNF Inhibitors for the Treatment of Plaque Psoriasis Sales by Country
- 8.1.1 Europe TNF Inhibitors for the Treatment of Plaque Psoriasis Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
- 8.1.2 Europe TNF Inhibitors for the Treatment of Plaque Psoriasis Sales by Country (2020-2025)
- 8.1.3 Europe TNF Inhibitors for the Treatment of Plaque Psoriasis Sales Forecast by Country (2026-2031)
- 8.2 Europe TNF Inhibitors for the Treatment of Plaque Psoriasis Market Size by Country
- 8.2.1 Europe TNF Inhibitors for the Treatment of Plaque Psoriasis Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
- 8.2.2 Europe TNF Inhibitors for the Treatment of Plaque Psoriasis Market Size by Country (2020-2025)
- 8.2.3 Europe TNF Inhibitors for the Treatment of Plaque Psoriasis Market Size Forecast by Country (2026-2031)
- 9 Asia-Pacific by Country
- 9.1 Asia-Pacific TNF Inhibitors for the Treatment of Plaque Psoriasis Sales by Country
- 9.1.1 Asia-Pacific TNF Inhibitors for the Treatment of Plaque Psoriasis Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
- 9.1.2 Asia-Pacific TNF Inhibitors for the Treatment of Plaque Psoriasis Sales by Country (2020-2025)
- 9.1.3 Asia-Pacific TNF Inhibitors for the Treatment of Plaque Psoriasis Sales Forecast by Country (2026-2031)
- 9.2 Asia-Pacific TNF Inhibitors for the Treatment of Plaque Psoriasis Market Size by Country
- 9.2.1 Asia-Pacific TNF Inhibitors for the Treatment of Plaque Psoriasis Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
- 9.2.2 Asia-Pacific TNF Inhibitors for the Treatment of Plaque Psoriasis Market Size by Country (2020-2025)
- 9.2.3 Asia-Pacific TNF Inhibitors for the Treatment of Plaque Psoriasis Market Size Forecast by Country (2026-2031)
- 10 South America by Country
- 10.1 South America TNF Inhibitors for the Treatment of Plaque Psoriasis Sales by Country
- 10.1.1 South America TNF Inhibitors for the Treatment of Plaque Psoriasis Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
- 10.1.2 South America TNF Inhibitors for the Treatment of Plaque Psoriasis Sales by Country (2020-2025)
- 10.1.3 South America TNF Inhibitors for the Treatment of Plaque Psoriasis Sales Forecast by Country (2026-2031)
- 10.2 South America TNF Inhibitors for the Treatment of Plaque Psoriasis Market Size by Country
- 10.2.1 South America TNF Inhibitors for the Treatment of Plaque Psoriasis Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
- 10.2.2 South America TNF Inhibitors for the Treatment of Plaque Psoriasis Market Size by Country (2020-2025)
- 10.2.3 South America TNF Inhibitors for the Treatment of Plaque Psoriasis Market Size Forecast by Country (2026-2031)
- 11 Middle East and Africa by Country
- 11.1 Middle East and Africa TNF Inhibitors for the Treatment of Plaque Psoriasis Sales by Country
- 11.1.1 Middle East and Africa TNF Inhibitors for the Treatment of Plaque Psoriasis Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
- 11.1.2 Middle East and Africa TNF Inhibitors for the Treatment of Plaque Psoriasis Sales by Country (2020-2025)
- 11.1.3 Middle East and Africa TNF Inhibitors for the Treatment of Plaque Psoriasis Sales Forecast by Country (2026-2031)
- 11.2 Middle East and Africa TNF Inhibitors for the Treatment of Plaque Psoriasis Market Size by Country
- 11.2.1 Middle East and Africa TNF Inhibitors for the Treatment of Plaque Psoriasis Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
- 11.2.2 Middle East and Africa TNF Inhibitors for the Treatment of Plaque Psoriasis Market Size by Country (2020-2025)
- 11.2.3 Middle East and Africa TNF Inhibitors for the Treatment of Plaque Psoriasis Market Size Forecast by Country (2026-2031)
- 12 Value Chain and Sales Channels Analysis
- 12.1 TNF Inhibitors for the Treatment of Plaque Psoriasis Value Chain Analysis
- 12.1.1 TNF Inhibitors for the Treatment of Plaque Psoriasis Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 TNF Inhibitors for the Treatment of Plaque Psoriasis Production Mode & Process
- 12.2 TNF Inhibitors for the Treatment of Plaque Psoriasis Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 TNF Inhibitors for the Treatment of Plaque Psoriasis Distributors
- 12.2.3 TNF Inhibitors for the Treatment of Plaque Psoriasis Customers
- 13 Concluding Insights
- 14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.